MedTrace Logo

Feasibility Study and Preliminary Application Study on Iris OCTA

NCT03631108 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2018-09-06

No results posted yet for this study

Summary

All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens. The main outcomes are iris blood flow density and vascular density.

Conditions

Interventions

DIAGNOSTIC_TEST

OCTA (ZEISS)

All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens.

Sponsors & Collaborators

  • Shanghai Eye Disease Prevention and Treatment Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2019-04-30
Completion
2019-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03631108 on ClinicalTrials.gov